Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Med

Chicago Med Is Adding A New Doctor For Season 9 After Losing Will, And I Hope This One Sticks Around

After Chicago Med said goodbye to Will Halstead, Season 9 will introduce a new doctor into the mix.

Cinemablend

Chicago P.D.'s Marina Squerciati Posed With Chicago Med Alums To Support The Strike, But The Kittens May Be The Real Stars

Some One Chicago stars reunited to support the SAG-AFTRA strikes, with some adorable kittens joining the cause.

Cinemablend

2 "B" Rated Medical Stocks to Buy Today, 1 to Closely Watch

The medical industry is well-positioned for growth due to increased healthcare spending, an aging population, and the rise in lifestyle-related diseases. To that end, it could be wise to buy fundamentally strong medical stocks Medifast (MED) and Zynex (ZYXI). On the other hand, Herbalife (HLF) could be added to one’s…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Chicago Med's Nick Gehlfuss Shares Thoughts On Ending Will's Run With That Big Finale Reunion

The Season 8 finale of Chicago Med said goodbye to Will Halstead, and actor Nick Gehlfuss opened up about how it happened.

Cinemablend

Chicago Med Said A Big Goodbye In Season 8 Finale, And I'm Flashing Back To Another Classic Medical Drama

Chicago Med is losing another character in a twist that left me reliving an iconic moment from another medical TV show.

Cinemablend

Chicago Med Keeps Dropping Clues About Will And Natalie, So Is Manstead Payoff Coming In The Finale?

The Season 8 finale of Chicago Med is coming, and the Manstead mentions seem to be piling up.

Cinemablend

Chicago Med Director Opens Up About The 'Definitely Different' Surgery On The Way For Archer, Plus Meeting The Cast

Director Nikki Taylor-Roberts spoke with CinemaBlend about coming to Chicago Med for an episode with a different kind of surgery for Dean Archer, and that's not all!

Cinemablend

Read news from The Economist, FT, and more,
with one subscription

Why Chicago Med's Huge Hospital Change Could Mean A Big Loss For The ED

The hits keep coming on Chicago Med, and another big loss may be on the way before the end of Season 8.

Cinemablend

Opioid crisis can’t be tackled without better pain management training for doctors

Many primary care practitioners are not adequately trained in pain management since learning about it is not required in medical school or during residency, a physician writes.

Chicago Sun-Times

Ice-T, LaRoyce Hawkins And More Stars React To Law And Order And One Chicago Show Renewals

The Law & Order and One Chicago action will continue into 2024, and members of the casts of the six shows had something to say about it!

Cinemablend

Chicago Med Just Revealed That Hannah's Tragic Backstory Goes Way Further Back Than Her Addiction, But Did She Make The Right Call?

Hannah's backstory is even sadder than Chicago Med ever let on before the latest episode, which resulted in a questionable call.

Cinemablend

Chicago Med Delivered A Surprise Throwback To Will And Natalie, But I'm Way More Invested In A Totally Different Duo

Chicago Med had a throwback to Manstead in its latest episode, but I'm ready for more of a different dynamic.

Cinemablend

How Chicago Med Avoided Saying Goodbye To Yet Another Cast Member

Chicago Med seemed on the verge of saying another goodbye in the latest episode!

Cinemablend

3 Dividend-Paying Stocks to Buy Now and Never Sell

The Fed’s indication of continuing rate hikes and impending recession fears is likely to keep the stock market under pressure for a while. Therefore, investors looking for a stable income can scoop up quality dividend-paying stocks PepsiCo (PEP), Medifast (MED), and Genie Energy (GNE) and hold forever. Read on….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

Highest in 3 yrs: LU gets 28,500 applications for 4,717 PG seats

LUCKNOW: Lucknow University (LU) has received highest number of applications for admission to its postgraduate courses in the last three years.

Benzinga

Medifast: Dividend Insights

Friday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE:MED).

Benzinga

Medifast Adopts $100M Accelerated Share Repurchase Program

Medifast Inc (NYSE:MED) has entered into an accelerated share repurchase agreement (ASR) with JPMorgan Chase, National Association. Under the agreement, Medifast will repurchase an aggregate of $100 million of its common stock. The buyback equates to about 600,000 shares at the closing price on May 31, 2022, representing 5% of its outstanding stock.…

Benzinga

Medifast Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q1, Medifast (NYSE:MED) earned $41.78 million, a 22.8% increase from the preceding quarter. Medifast also posted a total of $417.60 million in sales, a 10.52% increase since Q4.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: Medifast Q1 Earnings

Medifast (NYSE:MED) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Medifast beat estimated earnings by 0.56%, reporting an EPS of $3.59 versus an estimate of $3.57.

Benzinga

Earnings Outlook For Medifast

Medifast (NYSE:MED) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Medifast will report an earnings per share (EPS) of $3.56.

Benzinga

Medifast's Ex-Dividend Date Is Monday, Here's What You Need To Know

Friday marks the last chance for investors to receive the next dividend payout from Medifast (NYSE:MED).

1 2 3

People

George Clooney

1,142 stories

Dipanjan BanchurSince

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.